13 insiders reported 156 Form 4 transactions for JOHNSON & JOHNSON (JNJ) over the past 18 months (most recent 2026-09-04). Recent activity: Schmid Timothy (EVP, WW Chair, MedTech) Sell 11,070 shares, Schmid Timothy (EVP, WW Chair, MedTech) Buy 11,070 shares, Schmid Timothy (EVP, WW Chair, MedTech) Buy 22,527 shares, Schmid Timothy (EVP, WW Chair, MedTech) Sell 22,527 shares, Taubert Jennifer L (EVP, WWC. Innovative Medicine) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 11,070 | $3.0M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | Buy | 11,070 | $1.5M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | Buy | 22,527 | $3.4M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 22,527 | $6.2M |
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 15,000 | $1.7M |
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 15,000 | $4.0M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Buy | 123,291 | $14.3M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Sell | 20,976 | $5.5M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Sell | 102,315 | $26.7M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 9,344 | $2.4M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Buy | 9,344 | $1.2M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | Sell | 6,523 | $1.7M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | Sell | 41,957 | $10.8M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 6,574 | $1.7M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Buy | 11,129 | $1.4M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Buy | 11,925 | $1.6M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 23,054 | $5.8M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Buy | 10,000 | $1.2M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 10,000 | $2.4M |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | Buy | 25,255 | $0 |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 11,002 | $2.5M |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Buy | 4,075 | $471,355 |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Sell | 4,075 | $1.0M |
| 2026-02-23 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 | $324,763 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,302 | $0 |
Source: SEC Form 4 filings · as of 2026-09-04